[Follow-up after radiotherapy of anal canal carcinoma].
Anal canal carcinoma is a rare and curable disease for which the standard of care is radiation therapy with concurrent 5-fluoro-uracil and mitomycine-based chemotherapy. Post-treatment follow-up however is rather poorly defined. This article offers a review of the various post-treatment surveillance options both for early diagnosis of relapse and care for late treatment effects. While follow-up remains mostly clinical, we will discuss morphologic (endorectal echoendoscopy, pelvic magnetic resonance imaging, tomodensitometry and positron emission tomography) and biologic (squamous cell carcinoma antigen and pathology) follow-up so as to determine their diagnostic and prognostic value.
Service d'oncologie radiothérapie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France. Electronic address: n.meillan@laposte.net.
N
N
Meillan
Service d'oncologie radiothérapie, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France.
F
F
Huguet
Institut de cancérologie de Lorraine (Alexis-Vautrin), 6, avenue de Bourgogne, CS 30519, 54519 Vandœuvre-lès-Nancy cedex, France.
D
D
Peiffert
D001005:Anus Neoplasms / Q000532:radiotherapy*; D003663:Decision Trees; D005500:Follow-Up Studies; D006801:Humans
Anal carcinoma: Aftercare: Positron emission tomography; Carcinome épidermoïde du canal anal; Endosonography; Imagerie par résonance magnétique; Magnetic resonance imaging; Suivi post-thérapeutique; Tomographie par émission de positons; Échoendocopie endorectale